Lung adjuvant cisplatin evaluation (Lace Vinorelbine Project): Pooled analysis of adjuvant vinorelbine-cisplatin trials for completely resected non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Douillard, Jean-Yves
Tribodet, Helene
His, Patricia
Shepherd, Frances
Ding, Keyue
Winton, Timothy
Le Chevalier, Thierry
Spiro, Stephen
Stephens, Richard
Pignon, Jean-Pierre
机构：
[1] Ctr R Gauducheau, Nantes, France
[2] Inst Gustave Roussy, Villejuif, France
[3] PIerre Fabre Oncol, Boulogne, France
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Natl Canc Inst, Clin Trial Grp, Kingston, ON, Canada
[6] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada
[7] Middlesex Hosp, Dept Thorac Med, London, England
[8] MRC, Clin Trials Unit, London, England
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [31] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [32] Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Alvaro, G
    Colloca, G
    Landriscina, M
    Astone, A
    [J]. ONCOLOGY, 2000, 58 (01) : 25 - 30
  • [33] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [34] Gemcitabin, cisplatin (GP) versus vinorelbine, ifosfamide, cisplatin (NIP) in locally advanced non-small cell lung cancer (NSCLC)
    Certíková, G
    Eliasová, B
    Pesek, M
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 103 - 108
  • [35] Re-design of day case cisplatin/vinorelbine administration for adjuvant treatment of patients with non-small cell lung cancer
    MacLean, F.
    Hicks, J.
    [J]. LUNG CANCER, 2012, 75 : S9 - S9
  • [36] A randomized phase II feasibility study of adjuvant cisplatin/docetaxel (CisD) or cisplatin/vinorelbine (CisV) in patients (pts) resected stage IB-II non-small cell lung cancer (NSCLC): Interim analysis
    Galdermans, D.
    Driesen, P.
    Bustin, F.
    Lambrechts, M.
    Deschepper, K.
    Stappaerts, I.
    Verresen, D.
    Janssens, A.
    Germonpre, P. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Impact of histology on survival in resected patients with Non Small Cell Lung Cancer (NSCLC): Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation ANITA trial
    Douillard, J. Y.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 508 - 508
  • [38] Survival Data of Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine for Completely Resected NSCLC: A Retrospective Study
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Ono, Akira
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Naito, Tateaki
    Murakami, Haruyasu
    Kojima, Hideaki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S866 - S866
  • [39] ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)
    Rosell, R
    de Lena, M
    Carpagnano, F
    Ramlau, R
    Gonzalez-Larriba, J
    Grodzki, T
    Le Groumellec, A
    Aubert, D
    Gasmi, J
    Douillard, J
    [J]. LUNG CANCER, 2005, 49 : S3 - S4
  • [40] Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
    Kreuter, Michael
    Vansteenkiste, Johan
    Griesinger, Frank
    Hoffmann, Hans
    Dienemann, Hendrik
    De Leyn, Paul
    Thomas, Michael
    [J]. BMC CANCER, 2007, 7 (1)
12345